N-able Is Buying Back 5% of Itself While Guiding to a Slowdown

The stock had already voted. N-able's shares are up 25.5% over the last 90 trading days — a rare uptrend for a name that has shed 69% of its value since debuting at $16 in mid-2021 — and the tape shows it already fading 7% from a 90-day high set on October 28, a week before the print. Then the company reported, and the reason for that fade became legible.

A guide that decelerates on purpose

On the surface, the third quarter was unremarkable but intact: ARR of $553 million up 5% in constant currency, revenue of about $137 million up 5%, adjusted EBITDA margin of 32%. Total revenue has climbed 81% over five years. The problem is the forward shape. Fourth-quarter revenue is guided to $133-134 million, or 3-4% reported growth — the slowest quarter of the year — and full-year ARR lands at $558-560 million, 3-4% reported. Management then did something unusual: it pre-emptively framed 2027 off that decelerated number, with CFO Tim O'Brien calling the full-year 2026 constant-currency ARR growth “the right framing for 2027 top line performance, as we build toward acceleration over time” — Tim O'Brien, EVP and CFO · 2026-11-05.

Translation: don't model a reacceleration. CEO John Pagliuca was blunter about the philosophy, and it is the single most telling line on the call:

We want to realize the acceleration and not forecast the acceleration.

There is a real intellectual honesty to that — and a real admission buried inside it. In August, Pagliuca was telling investors the second half put the company in a “better position from an organic new product introduction, I think, than we've been for many quarters or many years” — John Pagliuca, President and CEO · 2026-08-10. Six months later, the guidance being handed over for 2027 is the same 5% constant-currency growth the company is delivering today, with additional investment layered on top.

Renewals: the number that never got fixed

The mechanical cause is gross retention, and it has now been stale for three consecutive quarters. Asked point-blank whether Q3 improved on Q2's mid-80s exit rate, O'Brien did not soften it: “We saw steady renewal rates in Q3 compared to Q2, and as we look into the Q4 guide, we've assumed, again, similar rates. So we haven't seen an improvement there on the renewal rates to date.” — Tim O'Brien, EVP and CFO · 2026-11-05 The renewal rate thread has been the company's most heavily weighted theme for two straight quarters, which tells you how much oxygen it is consuming internally.

The historical arc makes it worse. In August, O'Brien described the mechanism as it was happening: “we were seeing renewal rates in the higher 80s. And as we progress through the quarter, we saw them kind of middling out more in the mid-80s” — Tim OBrien, EVP and CFO · 2026-08-10. A year before that, in August 2025, the message was the opposite — Pagliuca told investors “customers are renewing at a very healthy clip... renewing at a clip around 90% or so.” — John Pagliuca, President and CEO · 2025-08-08 That 90% was about the long-term contract cohort, and it has since eroded. On this call, O'Brien put gross retention at 86% constant currency versus 87% in 2022 — a single point over four years, which quietly reframes the whole "AI pause" narrative.

What Pagliuca did add is arguably the more structural point, and it lands squarely on the small medium enterprise channel the company lives on: MSPs are no longer landing greenfield accounts, they are taking share from one another, and the pool of first-time outsourcers has matured. Half the churn is losing an MSP; the other half is retained MSPs spending less.

What is genuinely new: labor budgets, not software budgets

Buried in the prepared remarks is the most ambitious claim N-able has made in years. Reframing the under-pressure UEM franchise around autonomous endpoint management, Pagliuca argued that “over time, we believe this positions us to address not only software budgets, but also a portion of the labor budgets our customers incur today.” — John Pagliuca, President and CEO · 2026-11-05 That is the correct strategic answer to an MSP market where the technician is the cost constraint — and it is also an entirely unproven one, pitched against a customer base that has spent two quarters "taking a step back" on AI tooling.

The evidence that it is working so far is a set of small numbers presented as snowballs: DRaaS past $1 million in ARR within months of release, Google Workspace backup adding thousands of users on day one of preview, Cove past 4 million Microsoft 365 mailboxes and 200,000 businesses, security operations solidly past $50 million in ARR. It is a credible roster — the new SKUs basket is the entire bull case for 2027 — but each item is subscale relative to a $553 million ARR base, and management was explicit that none of it is in the guide yet.

Worth noting what lost weight in this transcript versus last quarter: the SentinelOne partnership thread and the AI agent narrative both faded from the top of the keyword stack, even as the CEO referenced them. The energy moved to the go-to-market reset under new CRO Russell Rosa — 90 days in, hiring technical sellers, pushing into Italy, France, DACH and Australia — and to the business resilience framing that stitches patching, SOC and recovery into one story. That is a distribution story, not a product story, and distribution fixes take several quarters to show up in ARR.

The buyback is doing the talking

Strip out the narrative and the capital allocation is the loudest signal. N-able repurchased 10.2 million shares for $38.7 million in Q3 — roughly 5% of shares outstanding — with $56 million left on the authorization, at a moment when effective net cash sits at -$282 million, net leverage is about 1.9x, the full $75 million delayed-draw term loan was tapped after quarter-end, and a $67 million Adlumin installment payment lands in Q4.

Meanwhile the cost side is inflating, not deflating. Capital expenditure jumped 159% year over year to $10 million. Free cash flow less stock-based comp fell 13% year over year to $7 million, and gross margin has slid to 76.8%, down 8 points from the 2022 peak. Research and development is running at roughly 20% of revenue — appropriate for the ambition, heavy for the growth rate.

This is where the valuation debate gets sharp. At 1.3x revenue — down 59% year over year, versus 6.7x in mid-2023 — against a $929 million market cap and guided full-year unlevered free cash flow of $116-118 million, the arithmetic looks like a double-digit cash yield. But unlevered FCF is not the same animal as the free cash flow net of stock compensation in the fundamentals, which is running near $7 million a quarter with cash interest of $28 million a year still to come. The bull case rests on the top line reaccelerating to something close to the 5% constant currency they just told you to use as a 2027 base; the bear case is that a mid-80s gross retention rate is a structural property of a maturing MSP channel, and buying back stock at 1.3x sales while levering up is a bet that the plateau is the floor. Q4 will not settle it — but the $558-560 million ARR landing spot, and whether the new SKUs show up in dollar-based net retention above 103% constant currency, will.